Mingyao Liu

Active 1987–2025

353
Papers
33,754
Citations
105
h-index
330
i10-index

Citations

Citations per year for Mingyao Liu1973: 1 citations1983: 1 citations1990: 1 citations1991: 1 citations1992: 1 citations1993: 6 citations1994: 2 citations1995: 9 citations1996: 16 citations1997: 24 citations1998: 42 citations1999: 38 citations2000: 48 citations2001: 46 citations2002: 58 citations2003: 108 citations2004: 100 citations2005: 156 citations2006: 147 citations2007: 146 citations2008: 178 citations2009: 176 citations2010: 149 citations2011: 208 citations2012: 215 citations2013: 176 citations2014: 239 citations2015: 169 citations2016: 241 citations2017: 262 citations2018: 251 citations2019: 888 citations2020: 1,187 citations2021: 1,249 citations2022: 1,202 citations2023: 970 citations2024: 1,759 citations2025: 986 citations2026: 35 citations1974–1982: no citations, so these years are not shown1984–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,639 citing papers, 27.3% of this breakdownUnited States: 2,916 citing papers, 21.9% of this breakdownUnited Kingdom: 568 citing papers, 4.3% of this breakdownCanada: 547 citing papers, 4.1% of this breakdownGermany: 541 citing papers, 4.1% of this breakdownItaly: 383 citing papers, 2.9% of this breakdownIndia: 375 citing papers, 2.8% of this breakdownJapan: 302 citing papers, 2.3% of this breakdownFrance: 293 citing papers, 2.2% of this breakdownSouth Korea: 274 citing papers, 2% of this breakdownAustralia: 264 citing papers, 2% of this breakdownSpain: 219 citing papers, 1.6% of this breakdown
0%27.3%Other 22.5%

Fields

  • Medicine42.2%
  • Biochemistry, Genetics and Molecular Biology38.8%
  • Immunology and Microbiology6.1%
  • Engineering3.1%
  • Neuroscience2.7%
  • Materials Science1.8%
  • Other5.3%

Topics

  • CRISPR and Genetic Engineering3.1%
  • Transplantation: Methods and Outcomes2.1%
  • Organ Transplantation Techniques and Outcomes1.6%
  • CAR-T cell therapy research1.4%
  • Immune cells in cancer1.3%
  • Virus-based gene therapy research1.1%
  • Other89.4%

Coauthors

All papers

Open in search
  1. Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 353

  2. Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jianhua Wang, Housheng Hansen He, Shancheng Ren - Nature Cell Biology 2021 cited by 538

  3. Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wenjing Ye, Lie Dai, Jian Zhu, Lingyun Sun, Biao Zheng, D. Li, Yanran He, Mingyao Liu, Huaxiang Wu, Bing Du, Huji Xu - Cell 2024 cited by 304

  4. Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 397

  5. Engineering a precise adenine base editor with minimal bystander editing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Chemical Biology 2022 cited by 185

  6. Re-engineering the adenine deaminase TadA-8e for efficient and specific CRISPR-based cytosine base editing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2022 cited by 156

  7. Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryos

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2023 cited by 117

  8. SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Cell 2019 cited by 247

  9. Normothermic Ex Vivo Lung Perfusion in Clinical Lung Transplantation

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 1,093

  10. CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2022 cited by 172

  11. Dual base editor catalyzes both cytosine and adenine base conversions in human cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2020 cited by 294

  12. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair

    Authors: , , , , , , , , , , , , - Circulation Research 2020 cited by 134

  13. Static lung storage at 10°C maintains mitochondrial health and preserves donor organ function

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2021 cited by 123

  14. LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption

    Authors: , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 cited by 368

  15. PGE2 activates EP4 in subchondral bone osteoclasts to regulate osteoarthritis

    Authors: , , , , , , , , , , , , , , , - Bone Research 2022 cited by 159

  16. Increasing the efficiency and targeting range of cytidine base editors through fusion of a single-stranded DNA-binding protein domain

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Cell Biology 2020 cited by 138

  17. Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study

    Authors: , , , , , , , , , , , , , , - EClinicalMedicine 2023 cited by 55

  18. RSPO2 and RANKL signal through LGR4 to regulate osteoclastic premetastatic niche formation and bone metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2021 cited by 89

  19. LIGHT/TNFSF14 promotes CAR-T cell trafficking and cytotoxicity through reversing immunosuppressive tumor microenvironment

    Authors: , , , , , , , , , , , , - Molecular Therapy 2023 cited by 62

  20. Preparation of copper-containing bioactive glass/eggshell membrane nanocomposites for improving angiogenesis, antibacterial activity and wound healing

    Authors: , , , , , , , , , - Acta Biomaterialia 2016 cited by 334

  21. Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2018 cited by 90

  22. Organ preservation: from the past to the future

    Authors: , , , , - Acta Pharmacologica Sinica 2018 cited by 213

  23. Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization

    Authors: , , , , , , , , , , , , - Cancer Research 2018 cited by 158

  24. Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , - EMBO Molecular Medicine 2020 cited by 111